Cerebral toxoplasmosis;Toxoplasmosis cerebral

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue SUPPL. 1, 1998, Pages 45-51

  Ribera Pascuet, Esteban ^a   López Aldeguer, José ^b   Pérez Elías, María Jesús ^c   Podzamczer Palter, Daniel ^d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ASTEMIZOLE; ATOVAQUONE; AZITHROMYCIN; CARBAMAZEPINE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; DIAZEPAM; DOXYCYCLINE; ERGOTAMINE; FLUOXETINE; LORAZEPAM; METHOTREXATE; PHENYTOIN; PYRIMETHAMINE; RIFABUTIN; RIFAMPICIN; SULFADIAZINE; SULFONAMIDE; TERFENADINE; THALLIUM 201; TRIAZOLAM; ZIDOVUDINE;

CYTOPENIA; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENCEPHALITIS; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; RASH; REVIEW; SERODIAGNOSIS; TOXOPLASMOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTI-HIV AGENTS; ANTIPROTOZOAL AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; TREATMENT FAILURE;

EID: 7844234049     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Ribera E. Toxoplasmosis. En: Rodés J, Guardia J, editores. Medicina interna. Barcelona: Masson, S.A. 1997; 1.849-1.852.
2. a ed.). Filadelfia: Lippincott-Raven Publishers, 1997; 641-659.
3. Renold C, Sugar A, Chave JP, Perrin I, Delavelle J, Pizzolato G et al. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) 1992; 71: 224-239.
4. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-222.
5. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D, Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990; 4: 519-521.
6. Zangerle R, Allerberger F, Pohl P, Fritsch P, Dierich MP. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 1991; 180: 59-66.
7. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1.643-1.648.
8. 8.The Quality Standards Subcomittee of the American Academy of Neurology. Evaluation and management of intracranial mass lesions in AIDS. Neurology 1998; 50: 21-26.
9. Antinori A, Ammassari A, De Luca A, Cingolani A, Murri R, Scoppettuolo G et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiological characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997; 48: 687-694.
10. Raffi F, Aboulker JP, Michelet C, Reliquet V, Pelloux H, Huart A et al. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997; 11: 177-184.
11. Podzamczer D, Santin M, Bolao F. Toxoplasmosis cerebral. En: Podzamczer D, Graus F, Clotet B, Portegies P, editores. Sistema nervioso y sida. Barcelona: JR Prous, S.A., 1995: 53-78.
12. a ed.). Filadelfia: Lippincott-Raven Publishers, 1997; 297-381.
13. Post MJD, Kursunoglu SJ, Henhsley GT, Chan JC, Moskowitz LB, Hoffman TA. Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique. Am J Roentgenol 1985; 145: 929-940.
14. Ciricillo SF, Rosenblum ML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J-Neurol Surg 1990; 73: 720-724.
15. Levy RM, Russell E, Yungbluth M, HIDvegi DF, Brody BA, Del Canto MC. The efficacy of imageguided stereotactic brain biopsy in neurologically symptomatic AIDS patients. Neurosurgery 1992; 30: 186-190.
16. Chapell ET, Guthrie BL, Orenstein J. The role of stereotactic brain lesions in the management of HIV-related focal brain lesions. Neurosurgery 1992; 30: 825-829.
17. Brain biopsy for intracranial mass lesions in AIDS [editorial]. Lancet 1992; 340: 1.135.
18. Luzzati R, Ferrari S, Nicolato A, Piovan E, Malena M, Merighi M et al. Stereotactic brain biopsy in HIV-infected patients. Arch Intern Med 1996; 5: 565-568.
19. Moskowitz LE, Henseley GT, Chan JC, Conley FK, Post MJD, González-Arias SM. Brain biopses in patients with AIDS. Arch Pathol Lab Med 1984; 108: 368-371.
20. Rodríguez JC, Martínez MM, Martínez AR, Royo G. Evaluation of different techniques in the diagnosis of Toxoplasma encephalitis. J Med Microbiol 1997; 46: 597-601.
21. Zufferey J, Sugar A, Rudaz P, Bille J, Glauser MP, Chave JP. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Microbiol Infect Dis 1993; 12: 591-595.
22. Holliman RE. Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 1990; 105: 415-418.
23. Derouin F, Mazeron MC, Garin YJF. Comparative studie of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii. J Clin Microbiol 1987; 25: 1.597-1.600.
24. Tirard V, Niel G, Rosenheim M, Katlama C, Ciceron L, Ogunkolade W et al. Diagnosis of toxoplasmosis in patients with AIDS by the isolation of the parasite from the blood. N Engl J Med 1991; 324: 634.
25. Asensi V, Carton JA, Maradona JA, Ona M, Arribas JM. Clinical value of blood cultures for detection of Toxoplasma gondii in HIV-seropositive patients with and without cerebral lesions on computerized tomography. Clin Infect Dis 1993; 17: 511-512.
26. Dupon M, Cazenave J, Pellegrin JL, Ragnaud JM, Cheyrou A, Fischer I et al. Detection of Toxoplasma gondii by PCR and tissue culture in CSF and blood of HIV-seropositive patients. J Clin Microbiol 1995; 33: 2.421-2.426.
27. Cohn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empirical treatment of suspected toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989; 86: 521-527.
28. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM et al. Toxoplasmic encephalitis in patients wi th the acquired immunodeficiency syndrome. N Engl J Med 1993; 329: 925-1.000.
29. Dina T. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 1991; 179: 823-828.
30. 201 brain SPECT to differenciate cerebral lymphoma from Toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994; 15: 1.885-1.894.
31. 201 single-photon emission computed tomography. Am J Roentgenol 1994; 163: 417-421.
32. Berry I, Gaillard JF, Guo Z, Cordoliani YS, Massip P, Manelfe C et al. Cerebral lesions in AIDS. What can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions. J Neuroradiol 1995; 22: 218-228.
33. Lorberboym M, Estok I, Machac J, Germano I, Sacher M, Feldman R et al. Rapid differential diagnosis of cerebrospinal toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nuc Med 1996; 37: 1.150-1.154.
34. Lomeña F, Vidal-Sicart S, Cruceta A, Pavía J, Miró JM, Mañé S et al. Predictive value of 201-thallium SPECT in the diagnosis of primary brain lymphoma in AIDS patients [resúmenes de la European Association of Nuclear Medicine Congress]. Eur J Nucl Med 1997; 24: 859.
35. Hoffman JM, Waskin HA, Schifter T, Hanson MW, Gray L, Rosenfeld S et al. FDG-PET in differentiating lymphoma from nonmalignan central nervous system lesions in patients with AIDS. J Nucl Med 1993; 34: 567-575.
36. Pierce MA, Johnson MD, Maciunas RJ, Murray MJ, Allen GS, Harbison MA et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995; 123: 594-598.
37. Gianotti N, Cinque A, Castagna R, Novati M, Moro M, Lazzarin A. Diagnosis of toxoplasmic encephalitis in HIV-infected patients. AIDS 1997; 11: 1.529-1.530.
38. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11: 1-17.
39. Parmley SF, Goebel FD, Remington JS. Detection of Toxoplasma gondii in CSF from AIDS patients by polymerase chian reaction. J Clin Microbiol 1992; 30: 3.000-3.002.
40. Lebech M, Lebech AM, Nelsing S, Vuust J, Mathiesen L, Petersen E. Detection of Toxoplasma gondii DNA by polymerase chian reaction in CSF from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165: 982-983.
41. Dupouy-Cament J, Lavareda S, Maslo C, Paugam A, Saimot AG, Benarous R et al. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol 1993; 31: 1.866-1.869.
42. Schoondermark-van de Ven E, Galama J, Fraaijeveld C, Van Druten J, Meuwissen J, Melchers W. Value of the polymerase chain reaction for the detection of Toxoplasma gondii in CSF from patients with AIDS. Clin Infect Dis 1993; 16: 661-666.
43. Novati R, Castagna A, Morsica G, Vago L, Tambussi G, Ghezzi S et al. Polymerase chain reaction for Toxoplasma gondii DNA in the CSF of AIDS patients with focal brain lesions. AIDS 1994; 8: 1.691-1.694.
44. Khalifa KE, Roth A, Roth B, Arasteh KN, Janitschke K. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994; 32: 2.813-2.819.
45. Lamoril J, Molina JM, Gouvello A, Garin YJ, Deybach JC, Modai J et al. Detection by PCR of Toxoplasma gondii in blood in the diagnosis of cerebral toxoplasmosis in patients with AIDS. J Clin Pathol; 49: 89-92.
46. Pelloux H, Dupouy-Camet J, Derouin F, Aboulker JP, Raffi F, and the Biotoxo Study Group. A multicentre prospective study for the polimerase chain reaction detection of Toxoplasma gondii DNA in blood samples from 186 AIDS patients with suspected toxoplasmic encephalitis. AIDS 1997; 11: 1.888-1.889.
47. 201thallium single photon emision tomography. AIDS 1997; 11: 1.522-1.523.
48. Danneman BR, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 1992; 116: 33-43.
49. Remington JS, Vilde JL. Clindamycin for toxoplasmic encephalitis in AIDS. Lancet 1991; 338: 1.142-1.143.
50. Katlama C. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS. Eur J Clin Microbiol Infect Dis 1991; 10: 189-191.
51. Podzamczer D, Gudiol F. Clindamycin in cerebral toxoplasmosis. Am J Med 1988; 84: 800.
52. Dhiver C, Milandre C, Poizot-Martin J, Drogoul MP, Gastaud JL, Gastaud JA. 5-fluoro-uracil-clindamycin for treatment of cerebral toxoplasmosis. AIDS 1993; 7: 143-144.
53. Fernández-Martín J, Leport C, Morlat P, Meyohas MC, Chauvin JP, Vilde JL. Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrob Agents Chemother 1991; 35: 2.049-2.052.
54. Saba J, Morlat P, Raffi F, Hazebroucq V, Joly V, Leport C et al. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur J Clin Microbiol Infect Dis 1993; 12: 853-856.
55. Kovacs JA, the NIAID-Clinical Center Intramural AIDS Program. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 1992; 340: 637-638.
56. Spencer CM, Goa KL. Atovaquone: a review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs 1995; 50: 176-196.
57. Morris JT, Kelly JW. Effective treatment of cerebral toxoplasmosis with doxycycline. Am J Med 1992; 93: 107-103.
58. Hagberg L, Palmertz B, Lindberg J. Doxycycline and pyrimethamine for toxoplasmic encephalitis. Scand J Infect Dis 1993; 25: 157-160.
59. Canessa A, Del Bono V, De Leo P, Piersantelli N, Terragna A. Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients. Eur J Clin Microbiol Infect Dis 1992; 11: 125-130.